• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Cells Release Insulin in Response to Music

      Cells Release Insulin in Response to Music

    • Radiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

    • Cardiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Photonic Radar Monitors Breathing from a Distance

      Photonic Radar Monitors Breathing from a Distance

    • Surgery
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Optical Strain Sensors for Rehab

      Optical Strain Sensors for Rehab

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Brain Computer Interface Decodes Speech and Facial Expressions

      Brain Computer Interface Decodes Speech and Facial Expressions

      Semi-Automated Manufacture of E-Skin Sensors

      Semi-Automated Manufacture of E-Skin Sensors

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Neuromyelitis Optics Therapy Market Analysis, Size, Share, Growth,– 2020 by Therapeutics Industry Driven By Regional Outlook, Current Trends, Product, Application, Drug, Business Opportunities

November 9th, 2020 Coherent Market Insights Releases

Global Neuromyelitis Optica Therapy Market Key Players

Key players operating in the global neuromyelitis optics therapy market include Alexion Pharmaceuticals Inc., Chugai Pharmaceutical Co., Ltd., Viela Bio, Inc, Hansoh Pharmaceutical Group Company Limited, AstraZeneca plc, F. Hoffmann-La Roche AG, Zydus Pharmaceuticals (USA) Inc., Alkem Laboratories, Hikma Pharmaceuticals USA Inc., and Sandoz Inc.

Neuromyelitis optica is an autoimmune disorder, in which white blood cells and antibodies attack optic nerve as well as spinal cord. Furthermore, damage of the optics nerves results in pain and loss of vision, while damage of spinal cord results in paralysis of legs or arms, loss of sensation in legs and arms, and problem in the function of bladder & bowel.

Request FREE Sample

Moreover, there is no cure for neuromyelitis optica disorder, but there are therapies to treat acute attack of relapses, and to reduce symptoms. Neuromyelitis optica attacks and Neuromyelitis optica relapses are often treated with plasma exchange and corticosteroids. Moreover, initial symptoms of neuromyelitis optica such as vision loss and paralysis can be improve with high doses of intravenous corticosteroids. On the other hand, plasma exchange can be used as alternative, if the patient do not respond to intravenous corticosteroids. For long term suppression of disease, immunosuppressive agents such as azathioprine, mycophenolate mofetil, and rituximab are used to prevent the attack. Sometimes, azathioprine and mycophenolate mofetil are used with the low doses of corticosteroid to prevent the attack.

Global Neuromyelitis Optica Therapy Market Drivers

The global neuromyelitis optica therapy market is expected to witness significant growth over the forecast period, owing to increasing collaborations to launch new drugs for the treatment of neuromyelitis optica spectrum disorder. For instance, in May 2019, in China, Viela Bio, Inc. entered into strategic collaboration with Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”) to develop as well as commercialize inebilizumab drug for the treatment of autoimmune disorder such as neuromyelitis optica spectrum disorder. From the same source, in May 2019, Viela Bio had presented positive result from the pivotal study of inebilizumab in patient. Moreover, currently inebilizumab drug is not approved by the U.S Food and Drug Administartion (FDA) for sale in China and U.S.

Special Requirements?
We value your investment and offer customization as per your requirements.

Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/4148

Furthermore, rising incidence of neuromyelitis optica disorder among people is expected to propel global neuromyelitis optica therapy market growth. For instance, according to the U.S National Library of Medicine (NHS) 2019 report, prevalence of neuromyelitis optica spectrum disorders (NMOSD) is commonly observed in nations with a predominately non-Caucasian population and estimated to be high as 10 per 100,000 individuals.

Global Neuromyelitis Optica Therapy Market Restraints

However, high cost of drug such as eculizumab for the treatment of neuromyelitis optica spectrum disorder (NMOSD) yet remains one of the major restraints for global neuromyelitis Optica therapy market growth. For instance, cost of eculizumab is US$ 500,000 per patient per year, which is one of the most expensive therapies in the world for the treatment of neuromyelitis optica spectrum disorder (NMOSD).

Moreover, side effects associated with the eculizumab such as upper respiratory tract infection, back pain, anemia, nasal congestion, urinary tract infection for the treatment of neuromyelitis optica spectrum disorder (NMOSD) is another factor that is expected to hamper the global neuromyelitis optica therapy market growth.

Global Neuromyelitis Optica Therapy Market Regional Analysis

Among regions, North America is expected to account for highest market share in the global neuromyelitis optica therapy market, owing to factors such as increasing approval of drugs for the treatment of neuromyelitis optica spectrum disorder (NMOSD) by company. For instance, in January 2019, Alexion Pharmaceuticals, Inc. received approval by the U.S Food and Drug Administartion (FDA) for eculizumab (Soliris) drug for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients.  Furthermore, from the same source, eculizumab (soliris) has reduced the need of corticosteroid and plasma exchange to prevent acute attack in patients, who are suffering from neuromyelitis optica spectrum disorder (NMOSD).

Asia Pacific is expected to exhibit highest CAGR in the global neuromyelitis optica therapy market in the forecast period due to increasing approval of drug for the treatment of neuromyelitis optica spectrum disorder (NMOSD) by company. For instance, in November 2019, Alexion Pharmaceuticals, Inc. received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for its Soliris (eculizumab) drug for the treatment of neuromyelitis optica spectrum disorder (NMOSD) to prevent relapse in patient.

Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/4148

Furthermore, increasing number of clinical trials of drug for the treatment of neuromyelitis optica spectrum disorder (NMOSD) by company is another factor that is expected to drive the global neuromyelitis optica therapy market growth. For instance, in September 2019, Chugai Pharmaceutical Co., Ltd.  announced positive results of its phase 3 clinical study of satralizumab drug, for the treatment of neuromyelitis optica spectrum disorder (NMOSD). From the same source, in 2019, Satralizumab had shown safety profile during the clinical trial and is first investigational drug that had demonstrated benefits both as a monotherapy and add-on therapy to baseline treatment in two different clinical trials. Furthermore, from the same source, in 2019, Chugai Pharmaceutical Co., Ltd also announced that they are going to collaborate with F. Hoffmann-La Roche AG Company. The main objective of this collaboration with Hoffmann-La Roche AG company is to file global regulatory application and bring Satralizumab as a potential new treatment to patients as soon as possible.

Furthermore, in October 2019, European Medicines Agency (EMA) and U.S. FDA accepted the marketing authorization of Satralizumab drug for the treatment of neuromyelitis optica spectrum disorder in adults and adolescent patients, which was announced by Chugai Pharmaceutical Co., Ltd.

To get a detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/4148

Market Taxonomy:

On the basis of drug class, the global neuromyelitis optics therapy market is segmented into:

  • Corticosteroids
  • Immunosuppressive Agents
    • Azathioprine
    • Mycophenolate Mofetil
    • Rituximab
    • Eculizumab
  • Others

On the basis of distribution channel, the global neuromyelitis optics therapy market is segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

On the basis of region, the global neuromyelitis optics therapy s market is segmented into:

  • North America
  • Latin America
  • Europe
  • Middle East
  • Asia Pacific
  • Africa

Other Related News:

Neurovascular Devices Market, by Device Type (Embolization Coils (Platinum Coils, Coated Platinum Coils, and Liquid Embolic Coils), Neurovascular Stents (Carotid Artery Stents and Flow Diversion Stents), Neurothrombectomy Devices (Clot Retrievers, Aspiration/ Suction Devices, and Vascular Snares), Embolic Protection Devices (Distal Filter Devices and Balloon Occlusion Devices), and Neurovascular Supporting Devices (Microcatheters and Microguidewires)), By Therapeutic Application (Cerebral Aneurysms, Ischemic Stroke, Cerebral Artery Stenosis, Arteriovenous Malformations (AVMs) and AV Fistulas, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Neurofibromatosis Treatment Drugs Market, by Disease Type (Neurofibromatosis 1 (NF1) and Neurofibromatosis 2 (NF2), and Schwannomatosis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Neurofibromatosis Type-1 Market, by Drug Class (Lamotrigine, Selumetinib, Others), By Distribution Channel (Hospitals, Speciality Clinics, Online Pharmacy, and Retail Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Sign up and submit a press release

Sponsored
Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Viral Vector Manufacturing in Gene Therapy and Vaccine Development

Health and Clean Air: Why Indoor Ventilation Matters

Health and Clean Air: Why Indoor Ventilation Matters

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

MedTech Outlook 2023 for Latin America Released

MedTech Outlook 2023 for Latin America Released

interviews & reviews
Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email